Home›Research›Compare›Ac-SDKP vs LL-37
Peptide ComparisonAc-SDKP vs LL-37
Both are Tissue Repair peptides.
Ac-SDKP
N-acetyl-seryl-aspartyl-lysyl-proline
No providers listed yet
LL-37 carries stronger published evidence (Cohort study, 19 key studies) than Ac-SDKP (Cohort study, 4); both are research compounds.
Ac-SDKP
Evidence
Half-life
—
LL-37
Evidence
Half-life
~30 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | LL-37 |
| More provider options (0 vs 38) | LL-37 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Ac-SDKP
LL-37
Ac-SDKP
Device surface-functionalized ac-SDKP nanoassemblies accelerate endothelial recovery through dual anti-inflam…
Ac-SDKP Attenuates Silica-Induced Pulmonary Fibrosis by Inhibiting ALKBH1-Mediated m(6)A Demethylation of miR…
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythe…
Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
LL-37
Immunomodulatory effects of synthetic antimicrobial peptides on LPS-induced inflammatory responses in THP-1 m…
The Role of Vitamin D in Modulating the Innate Immune Response in Children with Vesicoureteral Reflux.
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-ce…
+15 more
About Ac-SDKP
Inhibits hematopoietic stem cell entry into S-phase. Blocks TGF-β1-mediated fibroblast activation, reducing collagen deposition. Promotes angiogenesis via VEGF upregulation. Regulated in vivo by ACE enzyme.
About LL-37
Human cathelicidin antimicrobial peptide; disrupts bacterial membranes and modulates innate immune response via TLR signaling
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Ac-SDKP
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
LL-37
No established clinical contraindications
Ac-SDKP
Not enough vendor pricing yet.
LL-37
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Ac-SDKP vs LL-37 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ac-sdkp/ll-37